Next Article in Journal
COVID-19 Vaccine Booster Dose Acceptance among Older Adults
Next Article in Special Issue
Clinical Characteristics and Outcomes among Vaccinated and Unvaccinated Patients with Cardiovascular Disease Who Were Hospitalized for COVID-19 in Brazil: Retrospective Cohort
Previous Article in Journal
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously

1
Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, 101 Mineola Boulevard, Suite 4-004, Mineola, NY 11501, USA
2
SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY 13210, USA
3
College of Health Professions & Human Services, Department of Population Health, Hofstra University 1000 Hempstead Turnpike, Hempstead, NY 11549, USA
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(3), 541; https://doi.org/10.3390/vaccines11030541
Submission received: 23 January 2023 / Revised: 21 February 2023 / Accepted: 23 February 2023 / Published: 24 February 2023
(This article belongs to the Special Issue Cardiovascular Disease and COVID-19)

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic may result in cardiovascular complications such as myocarditis, while encephalitis is a potentially life-threatening COVID-19-associated central nervous system complication. This case illustrates the possibility of developing severe multisystem symptoms from a COVID-19 infection, despite having received the COVID-19 vaccine within the year. Delay in treatment for myocarditis and encephalopathy can lead to permanent and possibly fatal damage. Our patient, a middle-aged female with a complicated medical history, initially came in without characteristic manifestations of myocarditis such as shortness of breath, chest pain, or arrhythmia, but with an altered mental status. Through further laboratory tests, the patient was diagnosed with myocarditis and encephalopathy, which were resolved within weeks through medical management and physical/occupational therapy. This case presentation describes the first reported case of concomitant COVID-19 myocarditis and encephalitis after receiving a booster dose within the year.
Keywords: myocarditis; encephalopathy; COVID-19; ACE-2; dilated cardiomyopathy; Takutsobo myocarditis; encephalopathy; COVID-19; ACE-2; dilated cardiomyopathy; Takutsobo
Graphical Abstract

Share and Cite

MDPI and ACS Style

Saeedullah, U.; Abbas, A.M.; Ward, C.; Bayya, M.; Bhandari, J.; Abbas, A.M.; DeLeon, J.; Reiss, A.B. A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously. Vaccines 2023, 11, 541. https://doi.org/10.3390/vaccines11030541

AMA Style

Saeedullah U, Abbas AM, Ward C, Bayya M, Bhandari J, Abbas AM, DeLeon J, Reiss AB. A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously. Vaccines. 2023; 11(3):541. https://doi.org/10.3390/vaccines11030541

Chicago/Turabian Style

Saeedullah, Usman, Anas M. Abbas, Caitlin Ward, Maha Bayya, Jenish Bhandari, Araf M. Abbas, Joshua DeLeon, and Allison B. Reiss. 2023. "A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously" Vaccines 11, no. 3: 541. https://doi.org/10.3390/vaccines11030541

APA Style

Saeedullah, U., Abbas, A. M., Ward, C., Bayya, M., Bhandari, J., Abbas, A. M., DeLeon, J., & Reiss, A. B. (2023). A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously. Vaccines, 11(3), 541. https://doi.org/10.3390/vaccines11030541

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop